Mobile Health Cardiac Rehabilitation for Ischemia
Trial Summary
What is the purpose of this trial?
This is a multi-site phase II, 2:1 pragmatic randomized trial of 250 participants within the NYU Langone Health (NYULH) and Emory University Medical Center system to evaluate mobile health cardiac rehabilitation (mHealth-CR) in patients who meet clinical criteria for INOCA (ischemia and no obstructive coronary disease on imaging). Participants will be randomized to mHealth-CR or usual care. The study intervention takes place for 3 months which is the time period for most traditional CR programs. The overall study goals are threefold: 1) to evaluate whether an mHealth-CR intervention that includes activity tracking, weekly counseling, and exercise documentation, improves health status (i.e., symptoms, function, and quality of life) in patients with INOCA at 3 months; 2) to evaluate effects of the mHealth-CR intervention vs. usual care on physical activity and exercise capacity, general health status, and depressive symptoms (secondary endpoints). We will also evaluate effects on primary and secondary outcomes at 6 months and 1 year; and 3) to characterize engagement and elucidate any factors that limit engagement.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment mHealth-CR for ischemia?
Research shows that mobile health cardiac rehabilitation (mHealth-CR) can improve health-related quality of life and behavioral outcomes in patients recovering from heart issues like acute coronary syndrome. This suggests that using mobile technology to support cardiac rehabilitation can help patients manage their heart health better.12345
Is mobile health cardiac rehabilitation safe for humans?
How is the mHealth-CR treatment different from other treatments for ischemia?
The mHealth-CR treatment is unique because it uses mobile technology to deliver cardiac rehabilitation remotely, allowing patients to engage in their rehabilitation from home. This approach can help overcome barriers like distance and accessibility, making it easier for patients to participate in their recovery process compared to traditional in-person cardiac rehabilitation programs.245910
Research Team
Harmony Reynolds, MD
Principal Investigator
NYU Langone Health
Eligibility Criteria
This trial is for individuals with INOCA, which means they have symptoms of heart issues but no blocked arteries. They must be part of the NYU Langone Health or Emory University Medical Center system and willing to use a wearable device and communicate with an exercise therapist for 3 months.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive mHealth-CR intervention including activity tracking, weekly counseling, and exercise documentation for 3 months
Follow-up
Participants are monitored for safety and effectiveness after treatment, with evaluations at 6 months and 1 year
Treatment Details
Interventions
- mHealth-CR
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator